Digital messaging to support control for type 2 diabetes (StAR2D): a multicentre randomised controlled trial.

ABSTRACT:

Background

Failure to take medicines for diabetes as prescribed contributes to poor outcomes from the condition. Mobile phones are ubiquitous and short message service (SMS) texts have shown promise as a low-cost intervention. We tested the effectiveness of SMS-text messaging in improving outcomes in adults with type 2 diabetes.

Methods

StAR2D was a 12-month two-arm randomised trial of SMS-text messaging and usual care in Cape Town, South Africa and Lilongwe, Malawi. Messages used behaviour change theory and were developed with patients and staff. The intervention group received four messages each week. The primary outcome was change in HbA1c. Secondary outcomes were the proportion of patients who collected > 80% medication and changes in systolic blood pressure, lipids, car

SUBMITTER: Farmer A 

PROVIDER: S-EPMC8529732 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature